AURINIA PHARMACEUTICALS INC (AUPH) Stock Balance Sheet
NASDAQ:AUPH - CA05156V1022 - Common Stock
12.135 USD
-0.13 (-1.1%)
12.0501 USD
-0.08 (-0.7%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 52.91M | 83.40M | 48.76M | 94.20M | 231.90M | |||
| Marketable Securities | 262.13M | 275.04M | 301.61M | 295.20M | 234.20M | |||
| Receivables | 40.09M | 36.54M | 24.09M | 13.50M | 15.40M | |||
| Inventories | 46.50M | 39.23M | 39.70M | 24.80M | 19.30M | |||
| Other Current Assets | 7.33M | 12.38M | 10.64M | 14.90M | 12.50M | |||
| Total Current Assets | 408.97M | 446.60M | 424.80M | 442.50M | 513.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 89.45M | 98.87M | 116.57M | 8.60M | 9.80M | |||
| Investments And Advances | N/A | 0.00 | 201.00K | N/A | 0.00 | |||
| Intangibles | 4.05M | 4.36M | 4.98M | 6.40M | 8.40M | |||
| Other Non-Current Assets | 93.00K | 823.00K | 1.52M | 13.30M | 11.80M | |||
| Total Non-Current Assets | 93.59M | 104.05M | 123.26M | 28.40M | 30.10M | |||
| TOTAL ASSETS | 502.56M | 550.64M | 548.06M | 470.90M | 543.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 16.17M | 14.05M | 14.61M | N/A | N/A | |||
| Accrued Expenses | 48.39M | 66.00M | 50.38M | 28.60M | 32.10M | |||
| Accounts Payable | 3.31M | 5.19M | 4.33M | 11.70M | 3.90M | |||
| Other Current Liabilities | 10.39M | 12.53M | 7.87M | 5.80M | 4.60M | |||
| Total Current Liabilities | 78.27M | 97.76M | 77.19M | 46.10M | 40.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 59.28M | 58.55M | 75.48M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 29.71M | 16.85M | 17.44M | 19.30M | 23.60M | |||
| Total Non-Current Liabilities | 89.00M | 75.40M | 92.92M | 19.30M | 23.70M | |||
| TOTAL LIABILITIES | 167.26M | 173.17M | 170.11M | 65.40M | 64.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -891.71M | -936.57M | -942.32M | -864.30M | -756.10M | |||
| Additional Paid In Capital | 105.34M | 127.00M | 120.79M | 85.50M | 59.00M | |||
| Common Shares | 1.12B | 1.19B | 1.20B | 1.19B | 1.18B | |||
| Other Shareholders' Equity | -905.00K | -647.00K | -730.00K | -1.10M | -900.00K | |||
| Shares Outstanding | 132.67M | 140.88M | 143.83M | 142.30M | 141.60M | |||
| Tangible Book Value per Share | 2.50 | 2.65 | 2.59 | 2.80 | 3.32 | |||
| Total Shareholders' Equity | 335.30M | 377.48M | 377.95M | 405.40M | 479.10M | |||
| TOTAL LIABILITIES AND EQUITY | 502.56M | 550.64M | 548.06M | 470.90M | 543.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.18 | 0.16 | 0.20 | N/A | N/A | |||
| Current Ratio | 5.23 | 4.57 | 5.50 | 9.60 | 12.64 | |||
| Return On Assets (ROA) | 12.07% | 1.04% | -14.24% | -22.98% | -33.31% | |||
| Return On Equity (ROE) | 18.08% | 1.52% | -20.64% | -26.69% | -37.78% | |||
| Return On Invested Capital (ROIC) | 12.56% | 3.14% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 48.78% | 15.06% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 50.66% | 15.79% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.23